| Home | E-Submission | Sitemap | Contact Us |  
The Korean Journal of Medicine 2009;77(3): 377-381.
시프로프록사신에 반응하지 않은 해외유입 장티푸스 3예
김대범·김시현·오수진·김동규·최수미·김명신·신완식, , , , , ,
Three cases of ciprofloxacin treatment failure in imported typhoid fever
Dae-Bum Kim, Si-Hyun Kim, Su-Jin Oh, Dong Kyu Kim, Su-Mi Choi, Myungshin Kim, Wan-Shik Shin
Recently, the role of ciprofloxacin in the empirical treatment of typhoid fever has been limited with the increased incidence of nalidixic acid-resistant Salmonella enterica serovar Typhi in South-central and Southeast Asia, as well as multidrug-resistant strains. We experienced three cases of imported typhoid fever that did not respond to ciprofloxacin. All of the blood isolates were susceptible to ciprofloxacin in vitro, but the patients failed to achieve clinical improvement with ciprofloxacin and were treated with ceftriaxone or azithromycin. Although nalidixic acid-resistant strains may be reported as susceptible to ciprofloxacin on disk diffusion tests, they frequently show a poor clinical response to ciprofloxacin because of the increased minimum inhibitory concentration of ciprofloxacin. Therefore, if clinical improvement is delayed or fails with ciprofloxacin, imported typhoid fever from South-central or Southeast Asia should be considered as being due to nalidixic acid-resistant strains and should be treated with high-dose ciprofloxacin, ceftriaxone, or azithromycin. (Korean J Med 77:377-381, 2009)
Keywords: Typhoid fever; Drug resistance; Nalidixic acid; Ciprofloxacin
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Supplementary Material  Supplementary Material
A case of ciprofloxacin-induced severe immune thrombocytopenia  2005 May;69(3)
Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791   Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association of Internal Medicine. All rights reserved.                powerd by m2community